Equillium, Inc. revenue breakdown overview

Equillium, Inc. revenue for the last year amounted to 41.09 M USD, the most of which — 41.09 M USD — came from its highest performing source at the moment, Immuno-inflammatory Disorders Therapies, the year earlier bringing 36.08 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Equillium, Inc. 41.09 M USD, and the year before that — 36.08 M USD.